Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Navigate: Correlations HPO
There is one clinical trial.
This is phase II study to assess the efficacy of NestaCell® (mesenchymal stem cell) to treat severe COVID-19 pneumonia.
Description: Ordinal scale (WHO ordinal scale that measures illness severity over time)
Measure: Change in Clinical Condition Time: 10 daysDescription: Evaluation of Pneumonia change
Measure: Rate of mortality within 10-days Time: 10 daysDescription: Evaluation of Pneumonia change
Measure: Change of Clinical symptoms - respiratory rate Time: 10 daysDescription: oxygen saturation
Measure: Hypoxia Time: 10 daysDescription: oxygen saturation
Measure: PaO2 / FiO2 ratio Time: 10 daysDescription: Marker of Immunological function
Measure: CD4+ and CD8+ T cell count Time: Days 1, 2, 4, 6 and 8.Description: PaO2 / FiO2 ratio
Measure: Changes of blood oxygen Time: 10 daysDescription: Number of participants with treatment-related adverse events
Measure: Side effects in the treatment group Time: 10 daysDescription: Complete blood count, ALT, AST, GGT, CK, CKmB and creatinine
Measure: Complete blood count, cardiac, hepatic and renal profiles; Time: Days 1, 2, 4, 6 and 8.Alphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports